HomeMedicine
Medicine
Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
ALHAMBRA, Calif., Dec. 18, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that...
Envista Announces Participation in J.P. Morgan Healthcare Conference
BREA, Calif., Dec. 18, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 3:00 – 3:40 PM PST. There will be an audio-only recording link...
Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
CRANBURY, N.J., Dec. 18, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced it received a notice from the staff of NYSE American LLC...
Cano Health Announces Appointment of Two New Independent Directors
Patricia Ferrari and Carol Flaton to Enhance the Board's and Management's Ongoing Strategic, Operational and Financing Initiatives
MIAMI, Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced...
ETAO International Co. Ltd. Received Nasdaq Delisting Determination
NEW YORK, Dec. 18, 2023 /PRNewswire/ -- ETAO International Co. Ltd. announced today that it received a staff determination letter (the "Letter"), on December 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company of the determination...
Accorto Regulatory Solutions and Inter Scientific Enter Strategic Alliance to Deliver an Integrated Single-Point Solution for Clients USA – English APAC – English
RICHMOND, Va. and LIVERPOOL, England, Nov. 28, 2023 /PRNewswire/ -- Accorto Regulatory Solutions, LLC. (Accorto), a US-based regulatory firm specializing in helping small to mid-sized companies navigate the regulatory landscape to bring their FDA-regulated products to market, and Inter Scientific Ltd., an industry-leading, ISO...